KARYOPHARM.COM: Keyword Density Checker

Total words: 1610 | 2-word phrases: 415 | 3-word phrases: 454 | 4-word phrases: 469

PAGE INFO

Title	Try to keep the title under 60 characters (47 characters) Targeting Nuclear Export in Cancer \| Karyopharm
Description	Try to keep the meta description between 50 - 160 characters (206 characters) Karyopharm Therapeutics is an innovation-driven pharmaceutical company focused on the discovery, development, and commercialization of medicines with the goal of improving the lives of patients with cancer.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (32 characters) Inspired by Patients, Every day.

#	Keyword	Frequency	Density
1	learn more about	8	1.76%
2	patients with cancer	4	0.88%
3	both hematologic and	4	0.88%
4	and solid tumors	4	0.88%
5	hematologic and solid	4	0.88%
6	more about our	3	0.66%
7	solid tumors learn	3	0.66%
8	clinical trials karyopharm	3	0.66%
9	candidate and nextgeneration	2	0.44%
10	is the industry	2	0.44%
11	more about karyopharm	2	0.44%
12	lead drug candidate	2	0.44%
13	our lead drug	2	0.44%
14	karyopharm is the	2	0.44%
15	june 1 2024	2	0.44%
16	diseases learn more	2	0.44%
17	drug candidate and	2	0.44%
18	industry leader in	2	0.44%
19	the industry leader	2	0.44%
20	and other major	2	0.44%
21	leader in oral	2	0.44%
22	for our lead	2	0.44%
23	trials for our	2	0.44%
24	selective inhibitor of	2	0.44%
25	nuclear export sine	2	0.44%
26	export sine technology	2	0.44%
27	sine technology developed	2	0.44%
28	technology developed to	2	0.44%
29	karyopharm has ongoing	2	0.44%
30	trials karyopharm has	2	0.44%

#	Keyword	Frequency	Density
1	both hematologic and solid	4	0.85%
2	hematologic and solid tumors	4	0.85%
3	and solid tumors learn	3	0.64%
4	with cancer in both	2	0.43%
5	of improving the lives	2	0.43%
6	discovery development and commercialization	2	0.43%
7	development and commercialization of	2	0.43%
8	trials karyopharm has ongoing	2	0.43%
9	clinical trials karyopharm has	2	0.43%
10	karyopharm clinical trials karyopharm	2	0.43%
11	goal of improving the	2	0.43%
12	lives of patients with	2	0.43%
13	improving the lives of	2	0.43%
14	the lives of patients	2	0.43%
15	trials for our lead	2	0.43%
16	of patients with cancer	2	0.43%
17	diseases learn more about	2	0.43%
18	learn more about karyopharm	2	0.43%
19	more about patients who	2	0.43%
20	learn more about patients	2	0.43%
21	the discovery development and	2	0.43%
22	our lead drug candidate	2	0.43%
23	for our lead drug	2	0.43%
24	lines of treatment in	2	0.43%
25	tumor types across both	2	0.43%
26	trials and in a	2	0.43%
27	combination trials and in	2	0.43%
28	cancer in both hematologic	2	0.43%
29	treatment in combination trials	2	0.43%
30	of treatment in combination	2	0.43%
31	earlier lines of treatment	2	0.43%
32	karyopharm is the industry	2	0.43%
33	inspired by patients every	2	0.43%
34	by patients every day	2	0.43%
35	therapeutics is an innovationdriven	2	0.43%
36	is an innovationdriven pharmaceutical	2	0.43%
37	an innovationdriven pharmaceutical company	2	0.43%
38	drug candidate and nextgeneration	2	0.43%
39	lead drug candidate and	2	0.43%
40	medicines learn more about	2	0.43%

#	URL	Whois	Check
1	https://www.linkedin.com/company/karyopharm-therapeutics-inc/	Whois	linkedin.com
2	https://twitter.com/Karyopharm	Whois	twitter.com
3	https://twitter.com/Karyopharm	Whois	twitter.com